Company: GLRE
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001385613-25-000079
Chunk: 71

Company: GREENLIGHT CAPITAL RE, LTD.
Filing Date: 2025-08-04
Form: 10-Q
Item: Part I, Item 1
Chunk 71
---
Financial3,039 11 %3,192 13 %(153)4,823 9 %2,988 5 %1,835 Health2,296 8 %815 3 %1,481 5,931 11 %2,347 4 %3,584 Multiline12,099 44 %8,842 35 %3,257 26,803 49 %31,054 56 %(4,251)Specialty3,909 14 %2,465 10 %1,444 4,567 8 %4,538 8 %29 Total$27,597 100 %$25,320 100 %$2,277 $55,063 100 %$55,388 100 %$(325)

Gross premiums written within our Innovations segment in Q2 2025 increased by $2.3 million or 9.0%, compared to Q2 2024. The increase was predominantly attributable to the following lines of business:

•Multiline: The 36.8% increase was driven mostly by premium growth from our Syndicate 3456.

•Health: The 181.7% increase was mainly due to revised ultimate estimated premium written on certain legacy treaties, coupled with growth from 2024 quota share treaties and new business.

•Specialty: The 58.6% increase was predominantly from new quota share treaties bound in 2024.

Offset partially by:

•Casualty: The 37.5% decrease was mainly due to the non-renewal of a reinsurance program and a decrease in the line size of another quota share reinsurance treaty.

34

Gross premiums written within our Innovations segment in YTD 2025 decreased by $0.3 million or 0.6%, compared to YTD 2024. The decrease was predominantly attributable to the following lines of business:

•Multiline: The 13.7% decrease was driven mostly by lower premiums from our Syndicate 3456 and non-renewal of certain multiline quota share treaties with general liability exposure.

•Casualty: The 10.5% decrease was due to the same explanation as for Q2 2025.

The decrease was offset partially by:

•Health: The 181.7% increase was due to the same explanation as for Q2 2025.